WO2002053148A1 - Produits de soins dentaires contenant des derives d'ubiquinone - Google Patents

Produits de soins dentaires contenant des derives d'ubiquinone Download PDF

Info

Publication number
WO2002053148A1
WO2002053148A1 PCT/EP2001/015172 EP0115172W WO02053148A1 WO 2002053148 A1 WO2002053148 A1 WO 2002053148A1 EP 0115172 W EP0115172 W EP 0115172W WO 02053148 A1 WO02053148 A1 WO 02053148A1
Authority
WO
WIPO (PCT)
Prior art keywords
dental care
coenzyme
product according
care product
ubiquinone
Prior art date
Application number
PCT/EP2001/015172
Other languages
German (de)
English (en)
Inventor
Hans Michael Brecht
Peter Mentz
Manuela Yesil
Original Assignee
Hans Michael Brecht
Peter Mentz
Manuela Yesil
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hans Michael Brecht, Peter Mentz, Manuela Yesil filed Critical Hans Michael Brecht
Publication of WO2002053148A1 publication Critical patent/WO2002053148A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A61K8/355—Quinones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • the invention relates to a dentifrice containing ubiquinone derivatives for the therapeutic and / or preventive treatment of inflammatory and degenerative diseases of the gums and the tooth-holding apparatus.
  • ubiquinone derivatives encompasses those compounds which have a p-benzoquinone structural element, preferably those of the general formula (!),
  • n is an integer from 1 to 13, in particular 5 to 11.
  • mixtures of various ubiquinone derivatives can also be used.
  • the hydroquinone and quinone content of the substance can merge with one another by oxidation or reduction.
  • the loss of 2 ⁇ electrons in the oxidation removes the aromatic character, with the two remaining double bonds being fixed.
  • Quinone forms a redox system together with the hydroquinone, the potential of the hydrogen ion concentration and the ratio of the concentrations of the two components.
  • Coenzyme Q 10 is a yellow-orange crystalline substance with a melting point of 49 ⁇ 1 OC. It can hardly be found in water and
  • Coenzyme Q-io Dissolve methanol, but is somewhat soluble in ethanol, moderately soluble in fats such as corn oil and soybean oil, and very soluble in acetone, ether, chloroform, hexane and benzene.
  • Coenzyme Q-io is stable at room temperature for at least 3 years, but is not particularly durable in direct sunlight.
  • Coenzyme Q-io is similar to a lipid and can be regarded as a fat-soluble substance with a vitamin character.
  • Coenzyme Q 10 Due to its redox potential, Coenzyme Q 10 has antioxidative properties. It counteracts reactive oxygen species and free oxygen radicals, which occur primarily in the tissues of the body with ischemic and inflammatory changes. In this way, coenzyme Q 10 can have an anti-inflammatory effect, especially when applied locally, and protect the tissue against inflammatory and ischemic influences.
  • Enzyme activities are subject to change.
  • the invention specified in claim 1 is based on the problem of providing a means by means of which it is possible to sustainably suppress paradontal diseases in the population.
  • the invention thus relates to a dentifrice containing a carrier which is acceptable in dental care, optionally one or more auxiliaries and at least one ubiquinone derivative for the therapeutic and / or preventive treatment of inflammatory and degenerative diseases of the gums and the tooth-holding apparatus.
  • Another object of the invention is the use of ubichirion derivatives for the preparation of a dentifrice for therapeutic and / or preventive treatment of inflammatory and degenerative diseases of the gums and the tooth structure.
  • the invention furthermore relates to a method for the preventive treatment of inflammatory and degenerative diseases of the gums and the tooth-holding apparatus, a dental care composition containing an effective amount of an ubiquinone derivative being regularly applied to the teeth and gums of the persons concerned.
  • the ubiquinone derivative preferably a compound of the formula I, in particular coenzyme Q10, can be added in any form to the dentifrice according to the invention, for example
  • aqueous preparations e.g. in colloidal form, optionally in the presence of surfactants and / or stabilizers such as e.g. US 5,785,976, the disclosure of which is incorporated herein by reference; or
  • doctor as used above and below to designate the agent according to the invention includes pasteuse, gel or rubber-like agents which can be applied to the teeth and gums with the aid of brushes or by long-lasting chewing or sucking, it thus comprises toothpastes, toothpastes, tooth gels, sweets with sugar substitutes or substitutes and dental care chewing gum, toothpastes and dental care chewing gum being particularly preferred alcoholic-aqueous tooth washes are used. These include all types of mouthwashes and mouth sprays.
  • doctor as used above and below to designate the agent according to the invention also means periodontal therapeutic agents, gum bandages and denture adhesive creams.
  • composition of the dentifrice according to the invention is not critical per se with regard to the carrier materials and auxiliary substances.
  • it contains cleaning cleaning agents which are dispersed in an aqueous phase, various additives such as pigments, surfactants, thickeners, preservatives, caries-inhibiting fluorine compounds, flavoring and flavoring agents including sweeteners and salts, optionally colorants and other active ingredients.
  • Fine-particle, solid substances which have no sharp edges but instead have flat surfaces in powder form are preferably used as cleaning bodies, in particular calcium carbonate, precipitated lime, sludge chalk, pumice stone, calcium and magnesium phosphate, barium carbonate, glass powder, zeolites, mica, pearlite, coral lime, Talc, kaolin, bone substance, diatomaceous earth, aluminum oxide, silicon dioxide, silica gel, titanium dioxide, potassium hydroxide.
  • surfactants are sodium lauryl sulfate, sodium lauryl sarcosinate or sodium thaw.
  • toothpaste can contain fluorine compounds for caries prophylaxis, the ones to be used
  • Fluorine compounds are known to the person skilled in the art, preference is given to olaflur (N'-octadecyltrimethyldiamine-N, N, N , -tris (2-ethanol) dihydrofluoride), decaflur (9-octacecenylamine hydrofluoride), sodium fluoride and sodium monofluorophosphate. Vitamin A can also be added to increase periodontal prophylaxis.
  • glycerol for example disaccharides and / or sugar alcohols, and also polyethylene glycol, polypropylene glycol, PEG-40, castor oil, genuine, natural or synthetic sweeteners such as saccharin or sweetening peptides; Binders and thickeners, for example cellulose esters and ethers such as carboxymethyl celluloses or
  • hydroxyethylcelluloses Preservatives such as hydroxybenzoates, ascorbic acid or citric acid, dyes, flavorings such as peppermint oil or meat flavoring for use in pets, especially in dogs and cats, pigments.
  • Advantageous embodiments of the agent according to the invention are dental care agents with a content of 0.1 to 10.0% by weight, preferably 0.3 to 3.0% by weight, in particular approximately 0.5 to 2.5% by weight. on at least one ubiquinone derivative of the formula (I), in particular coenzyme Q 10 .
  • the dentifrice according to the invention in the form of a toothpaste has the following composition: Component part
  • the dental care chewing gum according to the invention is also regarding the
  • Carrier materials and auxiliary materials are not critical per se. As a rule, it contains a water-insoluble "gumbase” and a water-soluble portion, which contains flavorings. The water-soluble portion dissolves during chewing and the "gumbase” remains in the mouth during the chewing process.
  • the “gumbase” can contain elastomers, resins, fats, oils, plasticizers, waxes and inorganic fillers.
  • the elastomers can contain synthetic elastomers such as polyisobutylene, isobutylene-isoprene copolymers, styrene-butadiene
  • the chewing gum contains 5 to 95% by weight, preferably 10 to 50% by weight, in particular 20 to 35% by weight, of "gumbase”.
  • the water-soluble portion includes sweeteners, flavors, emulsifiers, colorings, acidulants, fillers, antioxidants and other components that give chewing gum the desired attributes.
  • the sweeteners include sugar and sugar-free components. Suitable sugars are sucrose, dextrose, maltose, dextrin, invert sugar, fructose, levulose, galactose. Sorbitol is preferably used as a sugar-free sweetener; In addition, mannitol, xylitol and other hydrogenated starch hydrolysates can also be used.
  • the chewing gum according to the invention generally contains 5 to 95% by weight, preferably 20 to 80% by weight, in particular 30 to 60% by weight, of one or more of these sweeteners.
  • artificial sweeteners such as sucralose, aspartame, salts of acesulfame, alitame, saccharin, cyclamate and gycyrrhizin and the like can be added.
  • the chewing gum according to the invention generally contains 0.02 to 8% by weight of one or more of these sweeteners.
  • peppermint oil For example, peppermint oil, spearmint oil, mint oil, anise oil and cinnamon come into consideration as flavorings.
  • the dental care product according to the invention in the form of a dental care chewing gum has the following composition: Component part
  • Sweetener especially sorbitol, mannitol, xylitol and aspartame 50 to 70 organic thickeners 0 to 3
  • Flavor especially peppermint or 0.1 to 2.0
  • the dentifrice according to the invention is usually administered regularly, preferably two to four times a day, in particular in the morning and in the evening and after meals with the aid of a toothbrush or directly, for example by chewing a dentifrice gum according to the invention or sucking a sugar-free candy on the teeth and / or the gums applied and massaged if necessary.
  • 1 to 100 mg, preferably 3 to 40 mg, of ubiquinone derivative is applied to each application.
  • the dentifrice according to the invention can be further modified and perfected within the scope of the following claims.
  • a certain synergistic effect can occur between coenzyme Q10 and vitamin A in certain patient groups.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne un produit de soins dentaires contenant des dérivés d'ubiquinone, destiné au traitement thérapeutique et/ou préventif d'affections inflammatoires et dégénératives des gencives et du parodonte.
PCT/EP2001/015172 2000-12-31 2001-12-20 Produits de soins dentaires contenant des derives d'ubiquinone WO2002053148A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10065413.4 2000-12-31
DE2000165413 DE10065413A1 (de) 2000-12-31 2000-12-31 Zahnpflegemittel

Publications (1)

Publication Number Publication Date
WO2002053148A1 true WO2002053148A1 (fr) 2002-07-11

Family

ID=7669256

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/015172 WO2002053148A1 (fr) 2000-12-31 2001-12-20 Produits de soins dentaires contenant des derives d'ubiquinone

Country Status (2)

Country Link
DE (1) DE10065413A1 (fr)
WO (1) WO2002053148A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003037284A1 (fr) * 2001-10-31 2003-05-08 Smithkline Beecham P.L.C. Composition pour hygiene buccale

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10312173A1 (de) * 2003-03-19 2004-09-30 Ingo Hornung Kaugummi mit beigemengten Mitteln
DE202009007704U1 (de) 2009-06-02 2009-08-20 Hurtig, Sven Zahnreinigungsmittel

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61286314A (ja) * 1985-06-11 1986-12-16 Shiseido Co Ltd 口腔用組成物
WO1994006418A1 (fr) * 1992-09-16 1994-03-31 Institut Für Sozial-Medizinische Forschung Composition a macher contenant le coenzyme q 10
WO1998056336A1 (fr) * 1997-06-12 1998-12-17 C.S. Bioscience Inc. Formulation dentaire
US5908613A (en) * 1997-09-08 1999-06-01 Bozzacco; Craig Composition for the treatment and prevention of periodontal disease
DE19802050A1 (de) * 1998-01-21 1999-07-22 Labtec Gmbh Zubereitung zur Freisetzung von Coenzym Q 10 in die Mundhöhle
WO2000033802A1 (fr) * 1998-12-11 2000-06-15 Q-Pharma, Inc. Compositions pour soins buccaux comprenant une coenzyme q¿10?

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61286314A (ja) * 1985-06-11 1986-12-16 Shiseido Co Ltd 口腔用組成物
WO1994006418A1 (fr) * 1992-09-16 1994-03-31 Institut Für Sozial-Medizinische Forschung Composition a macher contenant le coenzyme q 10
WO1998056336A1 (fr) * 1997-06-12 1998-12-17 C.S. Bioscience Inc. Formulation dentaire
US5908613A (en) * 1997-09-08 1999-06-01 Bozzacco; Craig Composition for the treatment and prevention of periodontal disease
DE19802050A1 (de) * 1998-01-21 1999-07-22 Labtec Gmbh Zubereitung zur Freisetzung von Coenzym Q 10 in die Mundhöhle
WO2000033802A1 (fr) * 1998-12-11 2000-06-15 Q-Pharma, Inc. Compositions pour soins buccaux comprenant une coenzyme q¿10?

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 011, no. 150 (C - 422) 15 May 1987 (1987-05-15) *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003037284A1 (fr) * 2001-10-31 2003-05-08 Smithkline Beecham P.L.C. Composition pour hygiene buccale

Also Published As

Publication number Publication date
DE10065413A1 (de) 2002-12-12

Similar Documents

Publication Publication Date Title
DE60212673T2 (de) Zusammensetzungen zur linderung von xerostomie und zur behandlung von damit zusammenhängenden erkrankungen
RU2385709C2 (ru) Композиция для ухода за полостью рта для предупреждения появления зубного налета, содержащая экстракт магнолии
US20070098650A1 (en) Dental formulation
JP2010538074A (ja) 口腔乾燥症を治療するための歯磨剤組成物
US8303938B2 (en) Anti-calculus dental composition
KR101354923B1 (ko) 울금 추출물과 비파 추출물을 유효성분으로 포함하는 구강 위생 증진용 조성물
EP4044996A1 (fr) Composition de soins bucco-dentaires
KR20080079776A (ko) 식물의 꽃 절편을 포함하는 치약 조성물
KR20170103476A (ko) 금앵자 추출물을 포함하는 구강질환 예방 또는 치료용 조성물
JPH04182419A (ja) 口腔用組成物
WO2002053148A1 (fr) Produits de soins dentaires contenant des derives d'ubiquinone
US20240130937A1 (en) Oral care composition
JPS6388117A (ja) 口腔用組成物
DE68914451T2 (de) Mundversorgungsmittel.
KR20170120411A (ko) 스코폴레틴을 포함하는 구강질환 예방 또는 치료용 조성물
KR100387091B1 (ko) 홍화씨 추출물을 함유하는 구강위생 증진용 조성물
WO2006110183A2 (fr) Preparation dentifrice
KR20170103482A (ko) 연전초 추출물을 포함하는 구강질환 예방 또는 치료용 조성물
KR20170103494A (ko) 과체 추출물을 포함하는 구강질환 예방 또는 치료용 조성물
KR101818211B1 (ko) 우방자 추출물을 포함하는 구강질환 예방 또는 치료용 조성물
EP4389228A1 (fr) Composition de soin buccal contenant des polymères cellulosiques
KR20220080874A (ko) 구강용 조성물
KR20170120399A (ko) 제니스테인을 포함하는 구강질환 예방 또는 치료용 조성물
KR20170120414A (ko) 에스쿨레틴을 포함하는 구강질환 예방 또는 치료용 조성물
KR20170103517A (ko) 화피 추출물을 포함하는 구강질환 예방 또는 치료용 조성물

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP